These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29333306)

  • 1. Acute Cervical Dystonia Induced by Clebopride.
    Choi JK; Hong JY
    Case Rep Neurol Med; 2017; 2017():2834349. PubMed ID: 29333306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute dystonic reaction induced by a single dose of clebopride: A case report.
    Seo YW; Ko SH; Jang TC; Kim GM
    Medicine (Baltimore); 2019 May; 98(22):e15826. PubMed ID: 31145322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemifacial dystonia possibly induced by clebopride.
    Bosco D; Plastino M; Marcello MG; Mungari P; Fava A
    Clin Neuropharmacol; 2009; 32(2):107-8. PubMed ID: 19512962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of respiratory dyskinesia due to clebopride malate].
    Kawasaki H; Yamamoto M; Okayasu H; Wakayama Y
    Rinsho Shinkeigaku; 1991 Aug; 31(8):878-81. PubMed ID: 1764865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrabenazine-induced oculogyric crisis - a rare complication in the treatment of Gilles de la Tourette syndrome.
    Janik P; Figura M
    Neuropsychiatr Dis Treat; 2016; 12():497-9. PubMed ID: 26955276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nosology of tardive syndromes.
    Frei K; Truong DD; Fahn S; Jankovic J; Hauser RA
    J Neurol Sci; 2018 Jun; 389():10-16. PubMed ID: 29433810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs.
    Schneider SA; Udani V; Sankhla CS; Bhatia KP
    Mov Disord; 2009 Jun; 24(8):1226-9. PubMed ID: 19412963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR; McPhillips MA
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing antipsychotic-induced acute and tardive dystonia.
    Raja M
    Drug Saf; 1998 Jul; 19(1):57-72. PubMed ID: 9673858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute oculogyric crisis in a patient taking clebopride.
    Kim W; Lee KS; Kim YI; Kim JS
    Intern Med; 2008; 47(6):551-2. PubMed ID: 18344644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN; Matroos GE; Hoek HW; Kahn RS
    Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive oculogyric crisis associated with amisulpride monotherapy.
    Mendhekar DN; Lohia D; Kataria P
    J Postgrad Med; 2010; 56(4):305-6. PubMed ID: 20935407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tardive dystonia following the administration of clebopride].
    Sempere AP; Mola S; Flores J
    Rev Neurol; 1997 Dec; 25(148):2060. PubMed ID: 9528065
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity.
    Gerlach J; Hansen L
    J Psychopharmacol; 1993 Jan; 7(4):355-64. PubMed ID: 22290999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Setting the record straight: The nosology of tardive syndromes.
    Truong DD; Frei K
    Parkinsonism Relat Disord; 2019 Feb; 59():146-150. PubMed ID: 30528171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine-related tardive dystonia and tardive dyskinesia: a case report.
    Chen PY; Lin PY; Tien SC; Chang YY; Lee Y
    Gen Hosp Psychiatry; 2010; 32(6):646.e9-646.e11. PubMed ID: 21112461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulpiride-induced tardive dystonia.
    Miller LG; Jankovic J
    Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.